Clinical trial
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive…
NCT00479505 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00479505 |
|---|---|
| Title | Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder |
| Official title | A Multi-Center, Randomised, Parallel Group, Double-Blind, Placebo Controlled Estimation Study To Assess The Efficacy And Safety Of Modified Release UK-369,003 In The Treatment Of Men With Storage Lower Urinary Tract Symptoms (LUTS) With And Without Erectile Dysfunction (ED). |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Bladder, Overactive |
| Intervention type | Drug |
| Interventions | UK-369, 003, Placebo |
| Enrollment | 275 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | May 28, 2007 |
| Last update posted | Mar 23, 2011 |
| Countries | Australia, Canada, Chile, Colombia, Finland, France, Germany, Greece, Italy, Latvia, Norway, Poland and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: